Article Versions Notes

Martin Mena A, Négrier L, Treizebré A, Guilbert M, Bonnaire L, Daniau V, Leba Bonki G, Odou P, Genay S, Décaudin B. Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility. Pharmaceutics. 2023; 15(8):2069. https://doi.org/10.3390/pharmaceutics15082069

Martin Mena, Anthony, Laura Négrier, Anthony Treizebré, Marie Guilbert, Lucille Bonnaire, Valentine Daniau, Gabie Leba Bonki, Pascal Odou, Stéphanie Genay, and Bertrand Décaudin. 2023. "Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility" Pharmaceutics 15, no. 8: 2069. https://doi.org/10.3390/pharmaceutics15082069

Martin Mena, A., Négrier, L., Treizebré, A., Guilbert, M., Bonnaire, L., Daniau, V., Leba Bonki, G., Odou, P., Genay, S., & Décaudin, B. (2023). Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility. Pharmaceutics, 15(8), 2069. https://doi.org/10.3390/pharmaceutics15082069